The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

Journal of Internal Medicine

Volumn 244, Issue 5, 1998, Pages 379-386

  Leibovici, L ^a,b   Shraga, I ^a,b   Drucker, M ^a,b   Konigsberger, H ^a,b   Samra, Z ^a,b   Pitlik, S D ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotic treatment; Bacteraemia; Blood stream infection; Empirical; Fatality rate

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEPHALOSPORIN; METRONIDAZOLE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHILD; DIAGNOSTIC ACCURACY; FATALITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; ISRAEL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 0031762306     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00379.x     Document Type: Article

References (20)

1. Bryan CS, Reynolds KL, Brenner ER. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983; 5: 629-38.
2. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungaemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5: 54-70.
3. Ispahani P, Pearson NJ, Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med 1987; 63: 427-40.
4. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian university hospital. 1974-79 and 1988-89: changing etiology, clinical features and outcome. Clin Inject Dis 1994; 19: 246-56.
5. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177-84.
6. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807-12.
7. Jones GR, Lowes JA. The systemic inflammatory response syndrome as predictor of bacteraemia and outcome from sepsis. Q J Med 1996; 89: 515-22.
8. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189-93.
9. Berman JR, Zaran FK, Rybak MJ. Pharmacy-based antimicrobial-monitoring service. Am J Hosp Pharm 1992; 49: 1701-6.
10. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124: 884-90.
11. Tomasz A. Multiple antibiotic resistant pathogenic bacteria. N Engl J Med 1994; 330: 1247-51.
12. Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-9.
13. do ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344: 1329-32.
14. Meyers BR, Sherman E, Mendelson MH, Velasquez G, Srulevitch-Chin E, Hubbard M, Hirschman SZ. Bloodstream infections in the elderly. Am J Med 1989; 86: 379-84.
15. Gransden WR, Eykyn SJ, Phillips I, Rowe B. Bacteremia due to Escherichia coli. A study 861 episodes. Rev Infect Dis 1990; 12: 1008-18.
16. McCue JD. Improved mortality in gram-negative bacillary bacteremia. Arch Intern Med 1985; 145: 1212-6.
17. Watanakunakorn C, Jura J. Klebsiella bacteremia; a review of 196 episodes during a decade (1980-89). Scand J Infect Dis 1991; 23: 399-405.
18. Leibovici L, Konigsberger H, Pitlik SD, Samra Z, Drucker M. Patients at risk for inappropriate antibiotic treatment of bacteremia. J Intern Med 1992; 231: 371-4.
19. European Organization for Research and Treatment of Cancer (EORTC), International Antimicrobial Therapy Cooperative Group, and the National Cancer Institute of Canada - Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 1991; 163: 951-8.
20. Phillips I. Resistance as a cause of treatment failure. J Antimicrob Chemother 1986; 18 (Suppl. C): 255-60.